What Is The Current and Historic Market Size Analysis Of The DNA Microarray Market?
The dna microarray market has seen considerable growth due to a variety of factors.
• The DNA microarray market has grown quickly in recent years. It is expected to grow from $3.38 billion in 2024 to $3.79 billion in 2025, at a CAGR of 12.3%.
Factors contributing to this growth include pharmacogenomics, healthcare infrastructure development, collaborations, cost reductions, and increased public awareness.
What are the Market Size and Expected Growth Rates for the DNA Microarray Market?
The dna microarray market is expected to maintain its strong growth trajectory in upcoming years.
• The DNA microarray market will grow rapidly, reaching $5.98 billion in 2029 with a CAGR of 12.1%.
Growth drivers include personalized medicine, genomic hybridization, agricultural genomics, and chronic disease prevalence. Key trends include advancements in genomic research, increased funding, and integration with other technologies.
Which Key Drivers Are Propelling The DNA Microarray Market's Growth?
The DNA microarray market is expected to grow due to the rapid adoption of personalized medicine. Personalized medicine tailors treatments based on individual genetic profiles, which is made possible by advancements in omics technology and data integration. DNA microarrays play a critical role in this by analyzing gene expression patterns. In February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies in 2023, highlighting the market's growth.
What Are The Key Segments Within The Global DNA Microarray Market?
The DNA microarray market covered in this report is segmented –
1) By Type: Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Other Types
2) By Application: Gene Expression Analysis, Genotyping, Other Applications
3) By End-user: Pharmaceutical And Biotechnology Companies, Diagnostic Centers, Hospitals And Clinics, Academic And Research Institute, Other End-Users
Subsegments:
1) By Complementary DNA Microarrays: Gene Expression Profiling, Comparative Genomic Hybridization (CGH), Quantitative Analysis
2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays, Single Nucleotide Polymorphism (SNP) Arrays, DNA Methylation Arrays, Pathogen Detection Arrays
3) By Other Types: Protein-DNA Microarrays, Tissue Microarrays, Affinity Microarrays, Spotted DNA Microarrays
Pre-Book The DNA Microarray Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The DNA Microarray Market?
Companies in the DNA microarray market are developing advanced technologies that offer a two-day turnaround time to stay competitive. Thermo Fisher Scientific, a US-based biotechnology company, launched the Applied Biosystems CytoScan HD Accel array in August 2023, which provides fast, detailed genomic insights for applications in prenatal, postnatal, and oncology research.
Who Are the Key Players In The DNA Microarray Market?
Major companies operating in the DNA microarray market are:
• Roche Holding AG
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Illumina Inc.
• bioMérieux SA
• Schott AG
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Bioneer Corporation
• CapitalBio Technology Co. Ltd.
• Eurofins Genomics LLC
• Savyon Diagnostics Ltd.
• Oxford Gene Technology
• Sengenics Corporation LLC
• Affymetrix
• BioCat GmbH
• Scienion AG
• LC Sciences
• Arrayit Corporation
• Akonni Biosystems Inc.
• Arraystar Inc.
• Febit Holding GmbH
What Are The Regional Insights Into The DNA Microarray Market?
North America was the largest region in the DNA microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
